These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 34686406)

  • 1. Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities.
    Khunti K; Heerspink HJL; Lam CSP; Nicolucci A; Ramirez L; Surmont F; Fenici P; Kosiborod M
    J Diabetes Complications; 2021 Dec; 35(12):108077. PubMed ID: 34686406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program.
    Ji L; Bonnet F; Charbonnel B; Gomes MB; Kosiborod M; Khunti K; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Shimomura I; Watada H; Fenici P; Hammar N; Hashigami K; Macaraeg G; Surmont F; Medina J
    J Diabetes Complications; 2017 Jul; 31(7):1188-1196. PubMed ID: 28499961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comorbidity network for chronic disease: A novel approach to understand type 2 diabetes progression.
    Khan A; Uddin S; Srinivasan U
    Int J Med Inform; 2018 Jul; 115():1-9. PubMed ID: 29779710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the gaps in diabetes care in first nations communities with the reorganizing the approach to diabetes through the application of registries (RADAR): the project protocol.
    Eurich DT; Majumdar SR; Wozniak LA; Soprovich A; Meneen K; Johnson JA; Samanani S
    BMC Health Serv Res; 2017 Feb; 17(1):117. PubMed ID: 28166804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A practice-based research network focused on comparative effectiveness research in type 2 diabetes management.
    Anderson JE; Rhinehart AS; Reid TS; Cuddihy RM; Vlajnic A; Dalal MR; Gemmen E; Johnstone B; Abbaszadeh B; Reed J; Sheller J; Stewart J; Mozaffari E;
    Postgrad Med; 2013 May; 125(3):172-80. PubMed ID: 23748518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Framework to Understand the Progression of Cardiovascular Disease for Type 2 Diabetes Mellitus Patients Using a Network Approach.
    Hossain ME; Uddin S; Khan A; Moni MA
    Int J Environ Res Public Health; 2020 Jan; 17(2):. PubMed ID: 31963383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fracture risk and healthcare resource utilization and costs among osteoporosis patients with type 2 diabetes mellitus and without diabetes mellitus in Japan: retrospective analysis of a hospital claims database.
    Sato M; Ye W; Sugihara T; Isaka Y
    BMC Musculoskelet Disord; 2016 Nov; 17(1):489. PubMed ID: 27887655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of a global registry to evaluate real-world clinical outcomes in patients with atrial fibrillation and high risk of stroke treated with left atrial appendage occlusion using the AMPLATZER amulet device-Perspective of available/ongoing registries of catheter-based LAA occlusion.
    Hildick-Smith D; Diener HC; Schmidt B; Paul V; Settergren M; Teiger E; Camm J; Tondo C; Landmesser U
    Catheter Cardiovasc Interv; 2018 Feb; 91(3):540-547. PubMed ID: 28862376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology and correlates of osteoporotic fractures among type 2 diabetic patients.
    Goldshtein I; Nguyen AM; dePapp AE; Ish-Shalom S; Chandler JM; Chodick G; Shalev V
    Arch Osteoporos; 2018 Mar; 13(1):15. PubMed ID: 29502187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Type 2 Diabetes in Determining Retinal, Renal, and Cardiovascular Outcomes in Women With Previous Gestational Diabetes Mellitus.
    Retnakaran R; Shah BR
    Diabetes Care; 2017 Jan; 40(1):101-108. PubMed ID: 27821407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patients' education, and its impact on care outcomes, resource consumption and working conditions: data from the International Diabetes Management Practices Study (IDMPS).
    Gagliardino JJ; Aschner P; Baik SH; Chan J; Chantelot JM; Ilkova H; Ramachandran A;
    Diabetes Metab; 2012 Apr; 38(2):128-34. PubMed ID: 22019715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment quality indicators predict short-term outcomes in patients with diabetes: a prospective cohort study using the GIANTT database.
    Sidorenkov G; Voorham J; de Zeeuw D; Haaijer-Ruskamp FM; Denig P
    BMJ Qual Saf; 2013 Apr; 22(4):339-47. PubMed ID: 23386729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
    Dailey G
    Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Registry of people with diabetes in three Latin American countries: a suitable approach to evaluate the quality of health care provided to people with type 2 diabetes.
    Commendatore V; Dieuzeide G; Faingold C; Fuente G; Luján D; Aschner P; Lapertosa S; Villena Chávez J; Elgart J; Gagliardino JJ;
    Int J Clin Pract; 2013 Dec; 67(12):1261-6. PubMed ID: 24246207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methods and rationale of the DISCOVER CKD global observational study.
    Pecoits-Filho R; James G; Carrero JJ; Wittbrodt E; Fishbane S; Sultan AA; Heerspink HJL; Hedman K; Kanda E; Chen HT; Kashihara N; Sloand J; Kosiborod M; Kumar S; Lainscak M; Arnold M; Lam CSP; Holmqvist B; Pollock C; Fenici P; Stenvinkel P; Medin J; Wheeler DC
    Clin Kidney J; 2021 Jun; 14(6):1570-1578. PubMed ID: 34249352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A long-term quality-of-care score for predicting the occurrence of macrovascular diseases in patients with type 2 diabetes mellitus.
    Li PI; Wang JN; Guo HR
    Diabetes Res Clin Pract; 2018 May; 139():72-80. PubMed ID: 29481816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and Design for the J-DISCOVER Study: DISCOVERing the Treatment Reality of Type 2 Diabetes in a Real-World Setting in Japan-A Protocol.
    Katakami N; Mita T; Takahara M; Hashigami K; Kawashima M; Shimomura I; Watada H;
    Diabetes Ther; 2018 Feb; 9(1):165-175. PubMed ID: 29260460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular risk outcome and program evaluation of a cluster randomised controlled trial of a community-based, lay peer led program for people with diabetes.
    Riddell MA; Dunbar JA; Absetz P; Wolfe R; Li H; Brand M; Aziz Z; Oldenburg B;
    BMC Public Health; 2016 Aug; 16(1):864. PubMed ID: 27558630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Canadian HIV and aging cohort study - determinants of increased risk of cardio-vascular diseases in HIV-infected individuals: rationale and study protocol.
    Durand M; Chartrand-Lefebvre C; Baril JG; Trottier S; Trottier B; Harris M; Walmsley S; Conway B; Wong A; Routy JP; Kovacs C; MacPherson PA; Monteith KM; Mansour S; Thanassoulis G; Abrahamowicz M; Zhu Z; Tsoukas C; Ancuta P; Bernard N; Tremblay CL;
    BMC Infect Dis; 2017 Sep; 17(1):611. PubMed ID: 28893184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Longitudinal analysis of atherosclerotic cardiovascular disease risk and healthcare costs in newly diagnosed type 2 diabetes in a real-world setting.
    Weng W; Liang Y; Brett J; Hobbs T; Baeres FMM
    J Diabetes Complications; 2020 May; 34(5):107500. PubMed ID: 32173216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.